Physiology-wise, would the correction of elevated ROS in TRPML1 k.o. cells alleviate symptoms of diseases caused by TRPML1 deficiency (e.g. ML-IV, NPC)? The gene discussed is MCOLN1; the disease is mucolipidosis type IV.